Globus Medical Inc (GMED) stock
GMEDNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3044% below fair value
$70.53+0.54 (+0.77%)
Close on Nov 18, 2026Market cap $9.47BP/E 18.0Yield –
Globus Medical operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Globus Medical's operating income for the twelve months ending Jun 30, 2026 was $639.52M, up 127.2% year over year. For fiscal 2025 it was $479.82M, up 189.1% from the year before. Over ten years it grew 10.8% a year on average. The highest annual figure on record is $479.82M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $479.82M | +189.1% |
| FY2024 | Dec 31, 2024 | $165.99M | +24.7% |
| FY2023 | Dec 31, 2023 | $133.14M | -41.6% |
| FY2022 | Dec 31, 2022 | $227.95M | +32.6% |
| FY2021 | Dec 31, 2021 | $171.95M | +54.3% |
| FY2020 | Dec 31, 2020 | $111.43M | -35.2% |
| FY2019 | Dec 31, 2019 | $171.99M | +1.6% |
| FY2018 | Dec 31, 2018 | $169.33M | +4.6% |
| FY2017 | Dec 31, 2017 | $161.84M | +5.0% |
| FY2016 | Dec 31, 2016 | $154.14M | -10.5% |
| FY2015 | Dec 31, 2015 | $172.22M | +24.5% |
| FY2014 | Dec 31, 2014 | $138.36M | +36.1% |
| FY2013 | Dec 31, 2013 | $101.67M | -11.4% |
| FY2012 | Dec 31, 2012 | $114.79M | +17.9% |
| FY2011 | Dec 31, 2011 | $97.36M | +11.0% |
| FY2010 | Dec 31, 2010 | $87.69M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $182.43M | +139.7% |
| Q1 FY2026 | Mar 31, 2026 | $150.39M | +55.0% |
| Q4 FY2025 | Dec 31, 2025 | $169.34M | +181.0% |
| Q3 FY2025 | Sep 30, 2025 | $137.36M | +185.6% |
| Q2 FY2025 | Jun 30, 2025 | $76.11M | +53.4% |
| Q1 FY2025 | Mar 31, 2025 | $97.00M | +1113.0% |
| Q4 FY2024 | Dec 31, 2024 | $60.27M | +495.4% |
| Q3 FY2024 | Sep 30, 2024 | $48.10M | +11805.4% |
| Q2 FY2024 | Jun 30, 2024 | $49.62M | -25.1% |
| Q1 FY2024 | Mar 31, 2024 | $8.00M | -85.8% |
| Q4 FY2023 | Dec 31, 2023 | $10.12M | -81.3% |
| Q3 FY2023 | Sep 30, 2023 | $404.00K | -99.3% |
| Q2 FY2023 | Jun 30, 2023 | $66.21M | -2.3% |
| Q1 FY2023 | Mar 31, 2023 | $56.40M | +21.4% |
| Q4 FY2022 | Dec 31, 2022 | $54.03M | +196.9% |
| Q3 FY2022 | Sep 30, 2022 | $59.70M | +12.0% |
| Q2 FY2022 | Jun 30, 2022 | $67.78M | +47.7% |
| Q1 FY2022 | Mar 31, 2022 | $46.45M | -14.9% |
| Q4 FY2021 | Dec 31, 2021 | $18.20M | -68.9% |
| Q3 FY2021 | Sep 30, 2021 | $53.33M | +6.6% |
| Q2 FY2021 | Jun 30, 2021 | $45.88M | – |
| Q1 FY2021 | Mar 31, 2021 | $54.55M | +91.7% |
| Q4 FY2020 | Dec 31, 2020 | $58.54M | +17.1% |
| Q3 FY2020 | Sep 30, 2020 | $50.01M | +18.9% |
| Q2 FY2020 | Jun 30, 2020 | -$25.56M | -159.6% |
| Q1 FY2020 | Mar 31, 2020 | $28.45M | -23.3% |
| Q4 FY2019 | Dec 31, 2019 | $49.98M | – |
| Q3 FY2019 | Sep 30, 2019 | $42.06M | +9.8% |
| Q2 FY2019 | Jun 30, 2019 | $42.87M | +1.7% |
| Q1 FY2019 | Mar 31, 2019 | $37.08M | -18.7% |
| Q4 FY2018 | Dec 31, 2018 | $0 | -100.0% |
| Q3 FY2018 | Sep 30, 2018 | $38.30M | +7.0% |
| Q2 FY2018 | Jun 30, 2018 | $42.14M | +12.8% |
| Q1 FY2018 | Mar 31, 2018 | $45.63M | +13.2% |
| Q4 FY2017 | Dec 31, 2017 | $48.36M | +35.4% |
| Q3 FY2017 | Sep 30, 2017 | $35.80M | -4.9% |
| Q2 FY2017 | Jun 30, 2017 | $37.37M | – |
| Q1 FY2017 | Mar 31, 2017 | $40.31M | – |
| Q4 FY2016 | Dec 31, 2016 | $35.72M | – |
| Q3 FY2016 | Sep 30, 2016 | $37.65M | – |
See a number that looks wrong?